An observational study in HIV/AIDS and HIV Lipodystrophy Syndrome, sponsored by University of Sao Paulo General Hospital. Completed. Open to male participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2015-08-21.
Sponsored by University of Sao Paulo General Hospital · Observational
Background: Several studies have reported increased resting energy expenditure (REE) in people living with HIV/AIDS possibly due to changes in body composition that occurs in HIV lipodystrophy syndrome.
The aim of this study was to evaluate the influence of the use of lipid-lowering drugs in resting energy expenditure (REE) and total energy expenditure (TEE) in patients seropositive for HIV in treatment of lipodystrophy.
REE was measured by indirect calorimetry.
TEE was measured by doubly labeled water (DLW) technique and an activity monitor based on accelerometry (AM).
2,040 studies on the registry are indexed under Acquired Immunodeficiency Syndrome; 272 are open to participants now.
This study's enrollment of 45 is below the median of 236 across 355 observational studies indexed under Acquired Immunodeficiency Syndrome.
Browse Acquired Immunodeficiency Syndrome studies →University of Sao Paulo General Hospital is the lead sponsor of 595 studies on the registry; 98 are open to participants now.
Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Men previously diagnosed with HIV infection, on antiretroviral therapy.
Exclusion Criteria:
HIV-seropositive without lipodystrophy and no use of lipid-lowering drugs.
HIV-seropositive with lipodystrophy and no use of lipid-lowering drugs.
HIV-seropositive with lipodystrophy and use of lipid-lowering drugs.
Drug: use of lipid-lowering drugs.
The patients shoud be in use of a lipid-lowering drugs previouly, at least one month before of the begining of the study.
Also known as: statins and fibrates
Total Energy Expenditure (kcal/d)
Time frame: 14 day
Resting Energy Expenditure (kcal/d)
Time frame: 1 day
Correlation between doubly labeled water and accelerometer to measure total energy expenditure (ICC, 95% CI)
Time frame: 14 days
No study locations are listed for this record.
This study is completed, as verified in Aug 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Acquired Immunodeficiency Syndrome→
University of Sao Paulo General Hospital